Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-17-012614
Filing Date
2017-11-27
Accepted
2017-11-27 16:44:07
Documents
1
Period of Report
2017-11-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3111617sadan_wizepharma.html 3  
1 OWNERSHIP DOCUMENT f3111617sadan_wizepharma.xml 3 3188
  Complete submission text file 0001213900-17-012614.txt   4676
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Issuer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address HASHOONIT 10 HERZLIYA L3 4655507
Business Address
Sadan Simcha (Reporting) CIK: 0001721347 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52545 | Film No.: 171223336